$LXU
LSB INDUSTRIES, INC.

2021 Q1 Form 10-Q Financial Statement

#000156459021021940 Filed on April 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $98.12M $83.41M
YoY Change 17.63% -11.41%
Cost Of Revenue $90.06M $80.86M
YoY Change 11.37% -6.88%
Gross Profit $8.060M $2.551M
YoY Change 215.95% -65.14%
Gross Profit Margin 8.21% 3.06%
Selling, General & Admin $8.793M $10.01M
YoY Change -12.12% 38.51%
% of Gross Profit 109.09% 392.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $16.76M $17.59M
YoY Change -4.72% 4.55%
% of Gross Profit 207.97% 689.61%
Operating Expenses $8.793M $10.01M
YoY Change -12.12% 38.51%
Operating Profit -$470.0K -$6.987M
YoY Change -93.27% -9940.85%
Interest Expense $12.37M $1.327M
YoY Change 832.33% -87.92%
% of Operating Profit
Other Income/Expense, Net -$395.0K $675.0K
YoY Change -158.52% -401.34%
Pretax Income -$13.24M -$19.80M
YoY Change -33.15% 77.74%
Income Tax $42.00K -$339.0K
% Of Pretax Income
Net Earnings -$13.28M -$19.45M
YoY Change -31.73% 68.56%
Net Earnings / Revenue -13.53% -23.32%
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$0.63 -$691.5K
COMMON SHARES
Basic Shares Outstanding 36.85M 29.34M
Diluted Shares Outstanding 36.85M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.20M $37.50M
YoY Change -62.13% 72.81%
Cash & Equivalents $14.23M $37.48M
Short-Term Investments
Other Short-Term Assets $45.40M $42.70M
YoY Change 6.32% 3.64%
Inventory $19.20M $26.30M
Prepaid Expenses
Receivables $60.10M $50.73M
Other Receivables $0.00 $0.00
Total Short-Term Assets $139.0M $157.2M
YoY Change -11.6% 11.12%
LONG-TERM ASSETS
Property, Plant & Equipment $910.5M $928.4M
YoY Change -1.93% -3.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.52M
YoY Change 9.35%
Total Long-Term Assets $916.0M $952.9M
YoY Change -3.87% -3.26%
TOTAL ASSETS
Total Short-Term Assets $139.0M $157.2M
Total Long-Term Assets $916.0M $952.9M
Total Assets $1.055B $1.110B
YoY Change -4.97% -1.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.40M $54.01M
YoY Change 6.28% 8.24%
Accrued Expenses $39.30M $37.40M
YoY Change 5.08% -0.8%
Deferred Revenue
YoY Change
Short-Term Debt $8.200M $6.893M
YoY Change 18.96% 16.83%
Long-Term Debt Due $18.08M $9.665M
YoY Change 87.09% -21.26%
Total Short-Term Liabilities $124.3M $111.1M
YoY Change 11.87% 5.12%
LONG-TERM LIABILITIES
Long-Term Debt $463.7M $480.8M
YoY Change -3.57% 16.45%
Other Long-Term Liabilities $26.60M $19.70M
YoY Change 35.03% 9.44%
Total Long-Term Liabilities $463.7M $480.8M
YoY Change -3.57% 16.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $124.3M $111.1M
Total Long-Term Liabilities $463.7M $480.8M
Total Liabilities $645.8M $591.9M
YoY Change 9.1% -0.29%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $127.0M $219.5M
YoY Change
Total Liabilities & Shareholders Equity $1.055B $1.110B
YoY Change -4.97% -1.45%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$13.28M -$19.45M
YoY Change -31.73% 68.56%
Depreciation, Depletion And Amortization $16.76M $17.59M
YoY Change -4.72% 4.55%
Cash From Operating Activities $12.71M -$2.178M
YoY Change -683.61% -130.85%
INVESTING ACTIVITIES
Capital Expenditures $6.133M $10.74M
YoY Change -42.88% 50.91%
Acquisitions
YoY Change
Other Investing Activities -$198.0K -$179.0K
YoY Change 10.61% 1888.89%
Cash From Investing Activities -$5.935M -$10.56M
YoY Change -43.79% 48.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.808M 27.43M
YoY Change -132.11% -738.16%
NET CHANGE
Cash From Operating Activities 12.71M -2.178M
Cash From Investing Activities -5.935M -10.56M
Cash From Financing Activities -8.808M 27.43M
Net Change In Cash -2.032M 14.69M
YoY Change -113.83% -438.29%
FREE CASH FLOW
Cash From Operating Activities $12.71M -$2.178M
Capital Expenditures $6.133M $10.74M
Free Cash Flow $6.578M -$12.92M
YoY Change -150.93% 23816.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 lxu Related Party Commitment Obligation Percentage
RelatedPartyCommitmentObligationPercentage
0.50
CY2021Q1 lxu Number Of Settlement Agreements
NumberOfSettlementAgreements
3
CY2021Q1 lxu Related Party Commitment Obligation Percentage
RelatedPartyCommitmentObligationPercentage
0.50
CY2021Q1 lxu Number Of Settlement Agreements
NumberOfSettlementAgreements
3
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-18000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
247327000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8793000
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
263000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
468000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23376000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28338000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
149643000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13279000
CY2021Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
9511000
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
511000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-19452000
CY2020Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
8307000
CY2020Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
504000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
495000
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-64000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-13279000
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1245461
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
80860000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31283210
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83411000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98116000
CY2020Q1 lxu Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
315000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1058000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1373000
CY2020Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3036000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-36000
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-64000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8808000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27428000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2032000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14692000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-19452000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16762000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17592000
CY2021Q1 lxu Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
315000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17321000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7512000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-625000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2996000
CY2021Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-2265000
CY2020Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-3115000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8598000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3171000
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
10412000
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11805000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5065000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2873000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12711000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2178000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6133000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10737000
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-198000
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-179000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5935000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10558000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
30000000
CY2020Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
2570000
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3353000
CY2020Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2042000
CY2021Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5419000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16264000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22791000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14232000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37483000
CY2021Q1 lxu Number Of Facilities For Manufacture And Distribution Of Products
NumberOfFacilitiesForManufactureAndDistributionOfProducts
4
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates<span style="font-weight:normal;"> </span>–<span style="font-weight:normal;"> The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></p>
CY2021Q1 lxu Tax Benefit Recognized
TaxBenefitRecognized
greater than 50%
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13279000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-19452000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23376000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28338000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28343693
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28176205
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3122460
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2551168
CY2021Q1 lxu Product Liability Deductible Per Claim
ProductLiabilityDeductiblePerClaim
250000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
467389000
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
468000
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19081000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8669000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7564000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6706000
CY2021Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
6442000
CY2020Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
5837000
CY2021Q1 lxu Accrued Death And Other Executive Benefits
AccruedDeathAndOtherExecutiveBenefits
2533000
CY2020Q4 lxu Accrued Death And Other Executive Benefits
AccruedDeathAndOtherExecutiveBenefits
2539000
CY2021Q1 lxu Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1429000
CY2020Q4 lxu Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1890000
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
10006000
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
10816000
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
47055000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
36457000
CY2021Q1 lxu Accrued And Other Liabilities Noncurrent
AccruedAndOtherLiabilitiesNoncurrent
6333000
CY2020Q4 lxu Accrued And Other Liabilities Noncurrent
AccruedAndOtherLiabilitiesNoncurrent
6090000
CY2021Q1 lxu Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
40722000
CY2020Q4 lxu Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
30367000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
7729000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8648000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
481755000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
484190000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
18082000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
16801000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
463673000
CY2021Q1 lxu Insurance Coverage Of General Liability And Auto Liability Risks
InsuranceCoverageOfGeneralLiabilityAndAutoLiabilityRisks
100000000
CY2020Q1 lxu Gain Loss On Sale Natural Gas Forward Contracts
GainLossOnSaleNaturalGasForwardContracts
-700000
CY2020Q1 lxu Realized Gain Loss On Natural Gas Forward Contracts Held
RealizedGainLossOnNaturalGasForwardContractsHeld
-200000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 lxu Liability Reserve
LiabilityReserve
0
CY2020Q1 lxu Accrued Pre Judgment And Post Judgment Interest
AccruedPreJudgmentAndPostJudgmentInterest
1300000
CY2021Q1 lxu Gain Loss On Sale Natural Gas Forward Contracts
GainLossOnSaleNaturalGasForwardContracts
2700000
CY2021Q1 lxu Realized Gain Loss On Natural Gas Forward Contracts Held
RealizedGainLossOnNaturalGasForwardContractsHeld
1500000
CY2021Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-285000
CY2020Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
35000
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-285000
CY2020Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
35000
CY2021Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-80000
CY2020Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-753000
CY2021Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
407000
CY2020Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
379000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
327000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-374000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-339000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
contracts have an original expected duration of one year or less, for our contracts with a duration greater than one year at contract inception, the average remaining expected duration was approximately 18 months
CY2021Q1 lxu Weighted Average Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period
WeightedAverageRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod
P18M
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2700000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1000000.0
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1700000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-216000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-332000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18091000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20229000

Files In Submission

Name View Source Status
0001564590-21-021940-index-headers.html Edgar Link pending
0001564590-21-021940-index.html Edgar Link pending
0001564590-21-021940.txt Edgar Link pending
0001564590-21-021940-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lxu-10q_20210331.htm Edgar Link pending
lxu-10q_20210331_htm.xml Edgar Link completed
lxu-20210331.xsd Edgar Link pending
lxu-20210331_cal.xml Edgar Link unprocessable
lxu-20210331_def.xml Edgar Link unprocessable
lxu-20210331_lab.xml Edgar Link unprocessable
lxu-20210331_pre.xml Edgar Link unprocessable
lxu-ex311_6.htm Edgar Link pending
lxu-ex312_7.htm Edgar Link pending
lxu-ex321_8.htm Edgar Link pending
lxu-ex322_9.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending